RxDoctor Payments Data

Jacob Dutcher, MD

Interventional Cardiology · St Cloud, MNNPI 1619000999

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $86,840 of the $122,894 with a category attached, or 70.7%. Boston Scientific accounts for 77.2% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $53,699, 3.3 times the $16,185 reported in 2019.

$122,894in general payments, 2019–2025

Across 274 payments — averaging $448.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$95K
  • Abbott$20K
  • GE HealthCare$5K
  • Medtronic$2K
  • Abiomed$400
  • Edwards Lifesciences$365
  • plus $683 from 11 others
$986,017in research payments, 2019–2025

Across 192 payments — averaging $5135.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$476K
  • Abbott$290K
  • Boston Scientific$220K

What the payments were for

  • Consulting fees$26,25021%
  • Speaking & faculty fees$86,84071%
  • Travel & lodging$3,7683%
  • Food & beverage$5,9915%
  • Gifts$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$122,894 in reported general payments places this provider in the 85th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$174,945
Medicare patients
772
Services billed
1,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$33,419
Metoprolol Succinate71$1,653
Atorvastatin Calcium48$637
ClopidogrelClopidogrel Bisulfate41$512
Rosuvastatin Calcium35$344
Warfarin Sodium17$260
Losartan Potassium42$242
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$215
Lisinopril18$215
Carvedilol23$172
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$171
Amlodipine Besylate35$128
Spironolactone19$84
Hydrochlorothiazide16$32

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in St Cloud

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →